Selectivity of prandial glucose regulators: Nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells

European Journal of Pharmacology

Volumn 386, Issue 1, 1999, Pages 105-111

  Bokvist, Krister ^a   Høy, Marianne ^a   Buschard, Karsten ^b   Holst, Jens Juul ^c   Thomsen, Mads Krogsgaard ^a   Gromada, Jesper ^a  

^a NOVO NORDISK A S   (Denmark)

^b Kommunehospitalet DK 1399 ^*  (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Exocytosis; Glucagon; K(ATP) channel; Nateglinide; Repaglinide

Indexed keywords

CALCIUM; GLUCAGON; NATEGLINIDE; POTASSIUM CHANNEL; REPAGLINIDE;

ANIMAL TISSUE; ARTICLE; DRUG STRUCTURE; EXOCYTOSIS; GLUCAGON RELEASE; MALE; MEMBRANE DEPOLARIZATION; NONHUMAN; PANCREAS CELL; PATCH CLAMP; PRIORITY JOURNAL; RAT;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CALCIUM; CARBAMATES; CYCLOHEXANES; EATING; ELECTROPHYSIOLOGY; EXOCYTOSIS; GLUCAGON; GLUCOSE; HYPOGLYCEMIC AGENTS; ISLETS OF LANGERHANS; KINETICS; MALE; PATCH-CLAMP TECHNIQUES; PHENYLALANINE; PIPERIDINES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, INBRED LEW; STIMULATION, CHEMICAL;

EID: 0033462195     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00754-2     Document Type: Article

References (32)

1. Aguilar-Bryan L., Nichols C.G., Wechsler S.W., Clement J.P., Boyd A.E., Gonzales G., Herrera-Sosa H., Nguy K., Bryan J., Nelson D.A. Cloning of the β cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science. 268:1995;423-426.
2. Ashcroft F.M., Rorsman P. Electrophysiology of the pancreatic B-cell. Prog. Biophys. Mol. Biol. 54:1989;87-143.
3. 2+-dependent exocytosis in pancreatic β cells is mediated by a 65-kDa mdr-like P-glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 96:1999;5539-5544.
4. +-channels in rat pancreatic A-cells. Pflügers Arch. 438:1999;428-436.
5. 3H-glibenclamide in pancreatic islet cells. Diabetologia. 29:1986;259-261.
6. Consoli A., Nurjhan N., Reilly J.J., Bier D.M., Gerich J.E. Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. J. Clin. Invest. 86:1990;2038-2045.
7. DeFronzo R.A. Pathogenesis of Type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia. 35:1992;389-397.
8. Efendic S., Enzmann F., Nylén A., Uvnäs-Wallensten K., Luft R. Effect of glucose/sulfonylurea interaction on release of insulin, glucagon, and somatostatin from isolated perfused rat pancreas. Proc. Natl. Acad. Sci. U.S.A. 76:1979;5901-5904.
9. Eliasson L., Renström E., Ämmälä C., Berggren P.-O., Bertorello A.M., Bokvist K., Chibalin A., Deeney J.T., Flatt P.R., Gäbel J., Gromada J., Larsson O., Lindström P., Rorsman P. PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic β-cells. Science. 271:1996;813-815.
10. Flatt P.R., Shibier O., Szecowka J., Berggren P.O. New perspectives on the actions of sulphonylureas and hyperglycemic sulfonamides on the pancreatic β-cell. Diabete Metab. 20:1994;157-162.
11. Fuhlendorff J., Rorsman P., Kofod H., Brand C.L., Rolin B., MacKay P., Shymko R., Carr R.D. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes. 47:1998;345-351.
12. 2+ in pancreatic β-cells under metabolic inhibition. Br. J. Pharmacol. 120:1996;1191-1198.
13. Gerich J.C. Glucose in the control of glucagon secretion. Lefèbvre P.J. Handbook of Experimental Pharmacology. 66/II:1983;3-18 Springer Verlag, Berlin.
14. Grodsky G.M., Epstein G.H., Fanska R., Karam J.H. Pancreatic action of the sulfonulureas. Fed. Proc. 36:1977;2714-2719.
15. Gromada J., Dissing S., Kofod H., Frøkjær-Jensen J. Effects of the hypoglycaemic drugs repaglinide and glibenclamide in ATP-sensitive potassium-channels and cytosolic calcium levels in βTC3 cells and pancreatic beta-cells. Diabetologia. 38:1995;1025-1032.
16. 2+ channels. J. Gen. Physiol. 110:1997;217-228.
17. Groop L. Sulfonylureas in NIDDM. Diabetes Care. 15:1992;737-754.
18. Holst J.J. Evidence that glicentin contains the entire sequence of glucagon. Biochem. J. 187:1980;337-343.
19. Holst J.J. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. Biochem. J. 207:1982;381-388.
20. Ikenoue T., Akiyoshi M., Fujitani S., Okazaki K., Kondo N., Maki T. Hypoglycaemic and insulinotropic affects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexane-carbonyl)-D-phenylalanine (A-4166). Br. J. Pharmacol. 120:1997;137-145.
21. Josefsen K., Stenvang J.P., Kindmark H., Berggren P.-O., Horn T., Kjær T., Buschard K. Fluorescence-activated cell sorted rat islet cells and studies of the insulin secretory process. J. Endocrinol. 149:1996;145-154.
22. Lefèbvre P.J., Scheen A.J. The postprandial state and risk of cardiovascular disease. Diabet. Med. 15:1998;S63-S68.
23. Martell, A.E., Smith, R.M., 1971. Critical Stability Constants, Vol. 1, Amino Acids, Amines, Vol. 2, Plenum, New York.
24. Ozanne S.E., Guest P.C., Hutten J.C., Hales C.N. Intracellular location and molecular heterogeneity of the sulphonylurea receptor in insulin-secreting cells. Diabetologia. 38:1995;277-282.
25. Panten U., Burgfeld J., Goerke F., Rennicke M., Schwanstecher M., Wallasch A., Zünkler B.J., Lenzen S. Control of insulin secretion by sulfonylureas, meglinitide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochem. Pharmacol. 38:1989;1217-1229.
26. + channels in clonal pancreatic a cells. J. Biol. Chem. 268:1993;15221-15228.
27. Rizza R.A., Mandarino L.J., Gerich J.E. Mechanism and significance of insulin resistance in non-insulin- dependent diabetes mellitus. Diabetes. 30:1981;990-995.
28. + channels in α-TC glugagonoma and β-TC insulinoma cells. Diabetes. 42:1993;1760-1772.
29. Rorsman P., Hellman B. Voltage-activated currents in guinae pig pancreatic α2 cells. J. Gen. Physiol. 91:1988;223-242.
30. Samols E., Tyler J.M., Mialhe P. Suppression of pancreatic glucagon release by the hypoglycæmic sulphonylureas. Lancet. 1969;174-176.
31. Suzuki M., Fujikura K., Kotake K., Inagaki N., Seino S., Takata K. Imuno-localization of sulphonylurea receptor 1 in rat pancreas. Diabetologia. 42:1999;1204-1211.
32. +-channel in mouse pancreatic β-cells. Pflügers Arch. 407:1986;493-499.